At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PPH VanEck Pharmaceutical ETF
Trading 08-20 13:56:22 EDT
116.04
-1.24
-1.06%
High116.73Low115.50Vol120.22K
Open116.50D1 Closing117.28Amplitude1.05%
Mkt Cap1.01BTradable Cap1.01BTotal Shares8.69M
T/O13.96MT/O Rate1.38%Tradable Shares8.69M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Sector Update: Healthcare Stocks Fall Thursday Afternoon
MT Newswires Live  ·  14 minutes ago
Sector Update: Healthcare Stocks Fall Thursday Afternoon
Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says
Reuters  ·  00:43
Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says
Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC
Reuters  ·  00:40
Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC
Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets
TIPRANKS  ·  00:37
Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets
AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study
TIPRANKS  ·  00:32
AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study
Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch
TIPRANKS  ·  00:31
Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch
Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis
TIPRANKS  ·  00:30
Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis
Merck is Maintained at Buy by UBS
Dow Jones  ·  00:03
Merck is Maintained at Buy by UBS
Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win
Dow Jones  ·  08-20 23:30
Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win
Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says
MT Newswires Live  ·  08-20 23:28
Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says
Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B
TradingKey  ·  08-20 23:00
Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B
Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines
Reuters  ·  08-20 22:30
Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines
Moderna, Coinbase, Walmart, Deere, Alibaba, SpaceX, and More Stocks That Explain Today's Market
Dow Jones  ·  08-20 20:46
Moderna, Coinbase, Walmart, Deere, Alibaba, SpaceX, and More Stocks That Explain Today's Market
U.S. Stocks on the MOVE-Walmart, Atour Lifestyle, Wolfspeed
Reuters  ·  08-20 19:43
U.S. Stocks on the MOVE-Walmart, Atour Lifestyle, Wolfspeed
BMO Capital Sticks to Their Buy Rating for Merck & Company (MRK)
TIPRANKS  ·  08-20 19:17
BMO Capital Sticks to Their Buy Rating for Merck & Company (MRK)
Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027
Reuters  ·  08-20 19:08
Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027
RBC downgrades Merck on ‘unprecedented valuation’ after vaccine data
TIPRANKS  ·  08-20 18:35
RBC downgrades Merck on ‘unprecedented valuation’ after vaccine data
Merck price target raised to $166 from $141 at BofA
TIPRANKS  ·  08-20 17:50
Merck price target raised to $166 from $141 at BofA
Merck & Co Inc : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $150 from $142
THOMSON REUTERS  ·  08-20 17:34
Merck & Co Inc : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $150 from $142
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116
MT Newswires Live  ·  08-20 17:25
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116

Introduction

Company Name.
VanEck Pharmaceutical ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Issue price:
--